# Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight

> **NCT00120497** · — · UNKNOWN · sponsor: **Massachusetts General Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Fetal Growth Retardation

## Interventions

- **DRUG:** somatropin (rDNA)

## Key facts

- **NCT ID:** NCT00120497
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-07
- **Primary completion:** 2011-07
- **Final completion:** 2011-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2011-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00120497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00120497, "Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT00120497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*